Jul 16, 20191 min read
On April 3, 2019, the Food and Drug Administration (FDA or the Agency) published in the Federal Register a notice announcing a public hearing and the establishment of a docket to receive information regarding products containing cannabis or cannabis-derived compounds. The Food Marketing Institute (FMI) thanks the FDA for the opportunity to submit comments, and appreciated the Agency convening stakeholders to further the discussion around this important topic.
Full Comments